• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

世界内镜组织关于结肠镜检查和成像后结直肠癌的共识声明。

World Endoscopy Organization Consensus Statements on Post-Colonoscopy and Post-Imaging Colorectal Cancer.

机构信息

University Hospital of North Tees, Stockton-on-Tees, UK; Northern Institute for Cancer Research, Newcastle University, UK.

University Hospital of North Tees, Stockton-on-Tees, UK.

出版信息

Gastroenterology. 2018 Sep;155(3):909-925.e3. doi: 10.1053/j.gastro.2018.05.038. Epub 2018 Jun 27.

DOI:10.1053/j.gastro.2018.05.038
PMID:29958856
Abstract

BACKGROUND & AIMS: Colonoscopy examination does not always detect colorectal cancer (CRC)- some patients develop CRC after negative findings from an examination. When this occurs before the next recommended examination, it is called interval cancer. From a colonoscopy quality assurance perspective, that term is too restrictive, so the term post-colonoscopy colorectal cancer (PCCRC) was created in 2010. However, PCCRC definitions and methods for calculating rates vary among studies, making it impossible to compare results. We aimed to standardize the terminology, identification, analysis, and reporting of PCCRCs and CRCs detected after other whole-colon imaging evaluations (post-imaging colorectal cancers [PICRCs]).

METHODS

A 20-member international team of gastroenterologists, pathologists, and epidemiologists; a radiologist; and a non-medical professional met to formulate a series of recommendations, standardize definitions and categories (to align with interval cancer terminology), develop an algorithm to determine most-plausible etiologies, and develop standardized methodology to calculate rates of PCCRC and PICRC. The team followed the Appraisal of Guidelines for Research and Evaluation II tool. A literature review provided 401 articles to support proposed statements; evidence was rated using the GRADE (Grading of Recommendations Assessment, Development and Evaluation) system. The statements were voted on anonymously by team members, using a modified Delphi approach.

RESULTS

The team produced 21 statements that provide comprehensive guidance on PCCRCs and PICRCs. The statements present standardized definitions and terms, as well as methods for qualitative review, determination of etiology, calculation of PCCRC rates, and non-colonoscopic imaging of the colon.

CONCLUSIONS

A 20-member international team has provided standardized methods for analysis of etiologies of PCCRCs and PICRCs and defines its use as a quality indicator. The team provides recommendations for clinicians, organizations, researchers, policy makers, and patients.

摘要

背景与目的

结肠镜检查并非总能检测出结直肠癌(CRC)-一些患者在检查结果为阴性后会发展为 CRC。如果这种情况发生在下一次推荐检查之前,就称为间隔期癌症。从结肠镜质量保证的角度来看,这个术语过于局限,因此 2010 年创造了“结肠镜检查后结直肠癌(PCCRC)”一词。然而,PCCRC 的定义和计算发生率的方法在不同的研究中存在差异,使得结果无法进行比较。我们旨在标准化 PCCRC 和其他全结肠影像学检查后发现的 CRC(影像学后结直肠癌[PICRC])的术语、识别、分析和报告。

方法

由 20 名国际胃肠病学家、病理学家和流行病学家、一名放射科医生和一名非医学专业人员组成的团队开会制定了一系列建议,标准化了定义和类别(与间隔期癌症的术语保持一致),制定了一个确定最可能病因的算法,并制定了标准化方法来计算 PCCRC 和 PICRC 的发生率。该团队遵循了《评估研究和评估 II 工具指南》。文献综述提供了 401 篇文章,以支持提出的声明;使用 GRADE(推荐评估、制定和评估分级)系统对证据进行了评估。团队成员使用修改后的 Delphi 方法匿名投票表决。

结果

该团队提出了 21 项关于 PCCRC 和 PICRC 的全面指导声明。这些声明提出了标准化的定义和术语,以及定性审查、病因确定、PCCRC 发生率计算和结肠非结肠镜成像的方法。

结论

一个由 20 名成员组成的国际团队提供了标准化的方法来分析 PCCRC 和 PICRC 的病因,并将其定义为质量指标。该团队为临床医生、组织、研究人员、政策制定者和患者提供了建议。

相似文献

1
World Endoscopy Organization Consensus Statements on Post-Colonoscopy and Post-Imaging Colorectal Cancer.世界内镜组织关于结肠镜检查和成像后结直肠癌的共识声明。
Gastroenterology. 2018 Sep;155(3):909-925.e3. doi: 10.1053/j.gastro.2018.05.038. Epub 2018 Jun 27.
2
Causes of Post-Colonoscopy Colorectal Cancers Based on World Endoscopy Organization System of Analysis.基于世界内镜组织分析系统的结肠镜检查后结直肠癌病因。
Gastroenterology. 2020 Apr;158(5):1287-1299.e2. doi: 10.1053/j.gastro.2019.12.031. Epub 2020 Jan 8.
3
Post-colonoscopy colorectal cancers in a national fecal immunochemical test-based colorectal cancer screening program.基于国家粪便免疫化学检测的结直肠癌筛查项目中的结肠镜检查后结直肠癌
Endoscopy. 2024 May;56(5):364-372. doi: 10.1055/a-2230-5563. Epub 2023 Dec 15.
4
Root-cause Analysis of 762 Danish Post-colonoscopy Colorectal Cancer Patients.762 例丹麦结肠镜检查后结直肠癌患者的根本原因分析。
Clin Gastroenterol Hepatol. 2023 Nov;21(12):3160-3169.e5. doi: 10.1016/j.cgh.2023.03.034. Epub 2023 Apr 7.
5
Utilization and reproducibility of World Endoscopy Organization post-colonoscopy colorectal cancer algorithms: retrospective analysis.世界内镜组织结肠镜检查后结直肠癌算法的利用和可重复性:回顾性分析。
Endoscopy. 2022 Mar;54(3):270-277. doi: 10.1055/a-1409-5531. Epub 2021 May 4.
6
Systematic Review and Meta-analysis: The Three-year Post-colonoscopy Colorectal Cancer Rate as per the World Endoscopy Organization Methodology.系统评价与荟萃分析:根据世界内镜组织方法得出的结肠镜检查后三年结直肠癌发生率
Clin Gastroenterol Hepatol. 2025 Mar;23(4):519-530. doi: 10.1016/j.cgh.2024.07.039. Epub 2024 Aug 27.
7
Post-colonoscopy colorectal cancers identified by probabilistic and deterministic linkage: results in an Australian prospective cohort.基于概率和确定性关联的结肠镜检查后结直肠癌:澳大利亚前瞻性队列研究结果。
BMJ Open. 2019 Jun 21;9(6):e026138. doi: 10.1136/bmjopen-2018-026138.
8
Postcolonoscopy Colorectal Cancer in Sweden From 2003 to 2012: Survival, Tumor Characteristics, and Risk Factors.2003年至2012年瑞典结肠镜检查后结直肠癌:生存率、肿瘤特征及危险因素
Clin Gastroenterol Hepatol. 2020 Nov;18(12):2724-2733.e3. doi: 10.1016/j.cgh.2020.06.010. Epub 2020 Jun 15.
9
Risk of a post-colonoscopy colorectal cancer in patients with diverticular disease: a population-based cohort study.憩室病患者结肠镜检查后的结直肠癌风险:基于人群的队列研究。
Endoscopy. 2024 Jul;56(7):471-481. doi: 10.1055/a-2264-8199. Epub 2024 Feb 8.
10
Postcolonoscopy colorectal cancer: Prevalence, categorization and root-cause analysis based on the World Endoscopic Organization system.结肠镜检查后的结直肠癌:基于世界内镜组织系统的流行情况、分类和根本原因分析。
Gastroenterol Hepatol. 2024 Apr;47(4):319-326. doi: 10.1016/j.gastrohep.2023.05.014. Epub 2023 Jun 5.

引用本文的文献

1
Interval Colorectal Cancers in a Fecal Immunochemical Test-Based Screening Program.基于粪便免疫化学检测的筛查项目中的间隔期结直肠癌
JAMA Netw Open. 2025 Jul 1;8(7):e2523441. doi: 10.1001/jamanetworkopen.2025.23441.
2
Postcolonoscopy colorectal cancer: What we need to know in the age of screening and magnifying endoscopy techniques.结肠镜检查后结直肠癌:在筛查和放大内镜技术时代我们需要了解的内容。
World J Gastrointest Endosc. 2025 Jul 16;17(7):107430. doi: 10.4253/wjge.v17.i7.107430.
3
Rectal Location and Postcolonoscopy Colorectal Cancer Outcomes.
直肠位置与结肠镜检查后结直肠癌的结局
JAMA Netw Open. 2025 Jun 2;8(6):e2513391. doi: 10.1001/jamanetworkopen.2025.13391.
4
Patient- and endoscopist-related risk factors and etiological categorization of post-colonoscopy colorectal cancer.结肠镜检查后结直肠癌的患者及内镜医师相关危险因素和病因分类
Endosc Int Open. 2025 May 16;13:a25663380. doi: 10.1055/a-2566-3380. eCollection 2025.
5
Variation in Proximal Sessile Serrated Lesion Detection Rates During Non-screening Colonoscopies.非筛查性结肠镜检查期间近端无蒂锯齿状病变检出率的差异
Cureus. 2025 Apr 15;17(4):e82317. doi: 10.7759/cureus.82317. eCollection 2025 Apr.
6
Case-mix-adjusted mean number of polyps per 100 procedures: a new candidate gold standard colonoscopy key performance indicator.每100例手术的病例组合调整后息肉平均数量:一种新的候选结肠镜检查金标准关键绩效指标。
BMJ Open Gastroenterol. 2025 May 2;12(1):e001743. doi: 10.1136/bmjgast-2025-001743.
7
Assessment of the impact of power business intelligence on adenoma detection rate: a prospective observational trial.评估电力商业智能对腺瘤检出率的影响:一项前瞻性观察性试验。
BMC Gastroenterol. 2025 Apr 19;25(1):275. doi: 10.1186/s12876-025-03894-z.
8
New Concept of Colonoscopy Assisted by a Microwave-Based Accessory Device: First Clinical Experience.基于微波辅助设备的结肠镜检查新概念:首次临床经验
Cancers (Basel). 2025 Mar 22;17(7):1073. doi: 10.3390/cancers17071073.
9
Post-endoscopy esophageal squamous cell carcinoma with invasion of the muscularis mucosa or deeper detected in surveillance endoscopy after esophageal endoscopic resection.食管内镜切除术后监测性内镜检查中发现的侵袭黏膜肌层或更深层的内镜后食管鳞状细胞癌。
Esophagus. 2025 Apr 5. doi: 10.1007/s10388-025-01124-9.
10
Screening outcomes at second FIT screening in individuals with a first time negative FIT-result or low-risk adenomas: Results from a nationwide FIT screening program.首次粪便免疫化学试验(FIT)结果为阴性或低风险腺瘤患者第二次FIT筛查的结果:一项全国性FIT筛查项目的结果
Int J Cancer. 2025 Aug 15;157(4):698-708. doi: 10.1002/ijc.35419. Epub 2025 Mar 28.